Candel Therapeutics (CADL) Payables (2020 - 2025)
Candel Therapeutics recorded quarterly Payables of $1.1 million in Q4 2025, up 0.98% quarter-over-quarter from $1.1 million in Q3 2025, and up 376.37% year-over-year from $237000.0 in Q4 2024.
Candel Therapeutics' Payables history runs 6 years deep, the most recent figure standing at $1.1 million for Q4 2025.
- In Q4 2025, Payables rose 376.37% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.1 million (up 376.37% YoY), while the FY2025 annual figure was $1.1 million, up 376.37% from the prior year.
- Payables came in at $1.1 million for Q4 2025 at Candel Therapeutics, up from $1.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $2.0 million in Q2 2025 to a low of $237000.0 in Q4 2024.
- A 5-year average of $828210.5 and a median of $759000.0 in 2021 frame the typical range for Payables.
- Across the five-year window, Payables slumped 76.1% in 2022 and jumped 376.37% in 2025, its largest moves.
- Candel Therapeutics' Payables stood at $1.6 million in 2021, then plunged by 76.1% to $380000.0 in 2022, then rose by 11.05% to $422000.0 in 2023, then slumped by 43.84% to $237000.0 in 2024, then surged by 376.37% to $1.1 million in 2025.
- According to Business Quant data, Payables over the past three periods registered $1.1 million, $1.1 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | 1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 760,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Sep 30, 2024 | 296,000.00 |
| Jun 30, 2024 | 433,000.00 |
| Mar 31, 2024 | 472,000.00 |
| Dec 31, 2023 | 422,000.00 |
| Sep 30, 2023 | 250,000.00 |
| Jun 30, 2023 | 480,000.00 |
| Mar 31, 2023 | 592,000.00 |
| Dec 31, 2022 | 380,000.00 |
| Sep 30, 2022 | 970,000.00 |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.39 Mn |
| Dec 31, 2021 | 1.59 Mn |
| Sep 30, 2021 | 925,000.00 |
| Jun 30, 2021 | 759,000.00 |
| Dec 31, 2020 | 921,000.00 |